Principal Display Panel (8 mg)
Exalgo
Product Images NDC 54868-6387
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Exalgo (NDC 54868-6387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (16 mg)
Chemical Structure (Exalgo 1)
Mean Steady-state Plasma Concentration Profile (Exalgo 2)
Percent Reduction In Average Pain Intensity From Screening To Week 12 Or Final Visit (Exalgo 3)
This is a chart that compares the improvement in pain of patients who have taken EXALGO versus a placebo after 12 weeks of treatment. The chart shows the percentage of pain reduction/improvement for each group, but some of the percentages have been cutoff or replaced with the letter "W."*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
